{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:53:59Z","timestamp":1784584439976,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10096-018-3399-z","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T06:44:39Z","timestamp":1538981079000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Herpes zoster infection and statins: which implications in clinical practice?"],"prefix":"10.1007","volume":"38","author":[{"given":"Marco","family":"Zuin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Rigatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"L\u2019Erario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9164-9160","authenticated-orcid":false,"given":"Loris","family":"Roncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"3399_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","volume":"27","author":"AN Stein","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR (2009) Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 27:520\u2013529","journal-title":"Vaccine"},{"key":"3399_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Gilden D (2013) The global epidemiology of herpes zoster. Neurology 81:928\u2013930","journal-title":"Neurology"},{"key":"3399_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F (2011) Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 52:332\u2013340","journal-title":"Clin Infect Dis"},{"key":"3399_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2051013615599151","volume":"3","author":"RW Johnson","year":"2015","unstructured":"Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T (2015) Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines 3:109\u2013120","journal-title":"Ther Adv Vaccines"},{"key":"3399_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/bjd.14815","volume":"175","author":"A Matthews","year":"2016","unstructured":"Matthews A, Turkson M, Forbes H, Langan SM, Smeeth L, Bhaskaran K (2016) Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice Datalink. Br J Dermatol 175:1183\u20131194","journal-title":"Br J Dermatol"},{"key":"3399_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10096-015-2372-3","volume":"34","author":"HH Chen","year":"2015","unstructured":"Chen HH, Lin CL, Yeh CJ, Yeh SY, Kao CH (2015) Statins can increase the risk of herpes zoster infection in Asia. Eur J Clin Microbiol Infect Dis 34:1451\u20131458","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3399_CR7","doi-asserted-by":"publisher","first-page":"e0198263","DOI":"10.1371\/journal.pone.0198263","volume":"13","author":"MC Kim","year":"2018","unstructured":"Kim MC, Yun SC, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH (2018) Statins increase the risk of herpes zoster: a propensity score-matched analysis. PLoS One 13:e0198263","journal-title":"PLoS One"},{"key":"3399_CR8","doi-asserted-by":"publisher","first-page":"e111268","DOI":"10.1371\/journal.pone.0111268","volume":"9","author":"SD Chung","year":"2014","unstructured":"Chung SD, Tsai MC, Liu SP, Lin HC, Kang JH (2014) Herpes zoster is associated with prior statin use: a population-based case-control study. PLoS One 9:e111268","journal-title":"PLoS One"},{"key":"3399_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/cid\/cit745","volume":"58","author":"T Antoniou","year":"2014","unstructured":"Antoniou T, Zheng H, Singh S, Juurlink DN, Mamdani MM, Gomes T (2014) Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis 58:350\u2013356","journal-title":"Clin Infect Dis"},{"key":"3399_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CLEP.S104258","volume":"8","author":"AG O\u2019Keeffe","year":"2016","unstructured":"O\u2019Keeffe AG, Nazareth I, Petersen I (2016) Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data. Clin Epidemiol 8:123\u2013132","journal-title":"Clin Epidemiol"},{"key":"3399_CR11","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.2015.15629","volume":"316","author":"R Chou","year":"2016","unstructured":"Chou R, Dana T, Blazina I, Daeges M, Jeanne TL (2016) Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 316:2008\u20132024","journal-title":"JAMA"},{"key":"3399_CR12","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner \u017d, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group (2016) 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37:2999\u20133058","journal-title":"Eur Heart J"},{"key":"3399_CR13","doi-asserted-by":"publisher","unstructured":"Mohammad S, Nguyen H, Nguyen M, Abdel-Rasoul M, Nguyen V, Nguyen CD, Nguyen KT, Li L, Kitzmiller JP (2018) Pleotropic Effects of Statins: untapped potential for statin pharmacotherapy. Curr Vasc Pharmacol. \n                    https:\/\/doi.org\/10.2174\/1570161116666180723120608","DOI":"10.2174\/1570161116666180723120608"},{"key":"3399_CR14","doi-asserted-by":"publisher","first-page":"g2911","DOI":"10.1136\/bmj.g2911","volume":"348","author":"HJ Forbes","year":"2014","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ 348:g2911","journal-title":"BMJ"},{"key":"3399_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3399_CR16","doi-asserted-by":"publisher","first-page":"d7281","DOI":"10.1136\/bmj.d7281","volume":"343","author":"HL Hoek van den","year":"2011","unstructured":"van den Hoek HL, Bos WJ, de Boer A, van de Garde EM (2011) Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ 343:d7281","journal-title":"BMJ"},{"key":"3399_CR17","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","volume":"169","author":"IM Tleyjeh","year":"2009","unstructured":"Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T (2009) Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 169:1658\u20131667","journal-title":"Arch Intern Med"},{"key":"3399_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/jir695","volume":"205","author":"ML Vandermeer","year":"2012","unstructured":"Vandermeer ML, Thomas AR, Kamimoto L, Reingold A, Gershman K, Meek J, Farley MM, Ryan P, Lynfield R, Baumbach J, Schaffner W, Bennett N, Zansky S (2012) Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis 205:13\u201319","journal-title":"J Infect Dis"},{"key":"3399_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1089\/vim.2005.18.474","volume":"18","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, Bergeron M, M\u00e9thot S, Gigu\u00e8re JF, Tremblay MJ (2005) Statins could be used to control replication of some viruses, including HIV-1. Viral Immunol 18:474\u2013489","journal-title":"Viral Immunol"},{"key":"3399_CR20","doi-asserted-by":"publisher","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","volume":"12","author":"C Minassian","year":"2015","unstructured":"Minassian C, Thomas SL, Smeeth L, Douglas I, Brauer R, Langan SM (2015) Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med 12:e1001919","journal-title":"PLoS Med"},{"key":"3399_CR21","doi-asserted-by":"publisher","first-page":"e0181565","DOI":"10.1371\/journal.pone.0181565","volume":"12","author":"N Erskine","year":"2017","unstructured":"Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, Goldberg RJ, Singh S (2017) A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One 12:e0181565","journal-title":"PLoS One"},{"key":"3399_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","volume":"46","author":"SP Laing","year":"2003","unstructured":"Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760\u2013765","journal-title":"Diabetologia"},{"key":"3399_CR23","first-page":"150","volume":"5","author":"AD Mooradian","year":"2009","unstructured":"Mooradian AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150\u2013159","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"3399_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_37_17","volume":"18","author":"R Hajar","year":"2017","unstructured":"Hajar R (2017) Diabetes as \u201ccoronary artery disease risk equivalent\u201d: a historical perspective. Heart Views 18:34\u201337","journal-title":"Heart Views"},{"key":"3399_CR25","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.116.021407","volume":"133","author":"M Nayor","year":"2016","unstructured":"Nayor M, Vasan RS (2016) Recent update to the US cholesterol treatment guidelines: a comparison with international guidelines. Circulation 133:1795\u20131806","journal-title":"Circulation"},{"key":"3399_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS (2006) Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 6:358\u2013370","journal-title":"Nat Rev Immunol"},{"key":"3399_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152807780077291","volume":"6","author":"R Ghittoni","year":"2007","unstructured":"Ghittoni R, Lazzerini PE, Pasini FL, Baldari CT (2007) T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives. Inflamm Allergy Drug Targets 6:3\u201316","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"2","key":"3399_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","volume":"197","author":"K Mausner-Fainberg","year":"2008","unstructured":"Mausner-Fainberg K, Luboshits G, Mor A, Maysel-Auslender S, Rubinstein A, Keren G, George J (2008) The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 197(2):829\u2013839","journal-title":"Atherosclerosis"},{"key":"3399_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1086\/515702","volume":"178","author":"DE Jenkins","year":"1998","unstructured":"Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM (1998) Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 178:940\u2013948","journal-title":"J Infect Dis"},{"key":"3399_CR30","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1086\/375056","volume":"36","author":"DS Fedson","year":"2003","unstructured":"Fedson DS (2003) Pandemic influenza and the global vaccine supply. Clin Infect Dis 36:1552\u20131561","journal-title":"Clin Infect Dis"},{"key":"3399_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-319-07320-0_13","volume":"824","author":"G Paragh","year":"2014","unstructured":"Paragh G, Seres I, Harangi M, F\u00fcl\u00f6p P (2014) Dynamic interplay between metabolic syndrome and immunity. Adv Exp Med Biol 824:171\u2013190","journal-title":"Adv Exp Med Biol"},{"key":"3399_CR32","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R (2016) Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388:2532\u20132561","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3399-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T19:11:34Z","timestamp":1570475494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3399-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3399"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3399-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"12 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required for a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not required for a review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}